Iron Sequestration and Anemia of Inflammation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kemna, 2005, Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS, Blood, 106, 1864, 10.1182/blood-2005-03-1159
Nemeth, 2004, IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin, J Clin Invest, 113, 1271, 10.1172/JCI200420945
Holbein, 1980, Iron-controlled infection with Neisseria meningitidis in mice, Infect Immun, 29, 886, 10.1128/iai.29.3.886-891.1980
Beaumier, 1984, Inflammation triggers hypoferremia and de novo synthesis of serum transferrin and ceruloplasmin in mice, Infect Immun, 46, 489, 10.1128/IAI.46.2.489-494.1984
Bertini, 1989, Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin-1 on liver cytochrome P-450, plasma fibrinogen, and serum iron, J Leukoc Biol, 46, 254, 10.1002/jlb.46.3.254
Schaible, 2002, Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis, J Exp Med, 196, 1507, 10.1084/jem.20020897
Holbein, 1981, Enhancement of Neisseria meningitidis infection in mice by addition of iron bound to transferrin, Infect Immun, 34, 120, 10.1128/IAI.34.1.120-125.1981
NOYES, 1960, The role of the reticulo-endothelial cell in iron metabolism, Br J Haematol, 6, 43, 10.1111/j.1365-2141.1960.tb06216.x
Cartwright, 1966, The anemia of chronic disorders, Semin Hematol, 3, 351
Corwin, 2000, Anemia of the critically ill: “acute” anemia of chronic disease, Crit Care Med, 28, 3098, 10.1097/00003246-200008000-00079
Maccio, 2005, Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia, Blood, 106, 362, 10.1182/blood-2005-01-0160
Ludwig, 2004, Anemia in multiple myeloma, Clin Adv Hematol Oncol, 2, 233
Hastka, 1993, Zinc protoporphyrin in anemia of chronic disorders, Blood, 81, 1200, 10.1182/blood.V81.5.1200.1200
Taylor, 1996, Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients, Nephrol Dial Transplant, 11, 1079, 10.1093/oxfordjournals.ndt.a027459
Auerbach, 2004, Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial, J Clin Oncol, 22, 1301, 10.1200/JCO.2004.08.119
Kapoian, 2008, Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin, J Am Soc Nephrol, 19, 372, 10.1681/ASN.2007050606
Coyne, 2007, Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) study, J Am Soc Nephrol, 18, 975, 10.1681/ASN.2006091034
Delaby, 2008, Sequential regulation of ferroportin expression after erythrophagocytosis in murine macrophages: early mRNA induction by haem, followed by iron-dependent protein expression, Biochem J, 411, 123, 10.1042/BJ20071474
Ashby, 2009, Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease, Kidney Int, 75, 976, 10.1038/ki.2009.21
Hume, 1965, Anaemia of rheumatoid arthritis and iron therapy, Ann Rheum Dis, 24, 451, 10.1136/ard.24.5.451
Beamish, 1971, The measurement of reticuloendothelial iron release using iron-dextran, Br J Haematol, 21, 617, 10.1111/j.1365-2141.1971.tb02724.x
Auerbach, 2007, Clinical update: intravenous iron for anaemia, Lancet, 369, 1502, 10.1016/S0140-6736(07)60689-8
Bishu, 2006, Acute injury with intravenous iron and concerns regarding long-term safety, Clin J Am Soc Nephrol, 1, S19, 10.2215/CJN.01420406
Sengoelge, 2005, Potential risk for infection and atherosclerosis due to iron therapy, J Ren Nutr, 15, 105, 10.1053/j.jrn.2004.09.018
Sullivan, 2007, Macrophage iron, hepcidin, and atherosclerotic plaque stability, Exp Biol Med (Maywood), 232, 1014, 10.3181/0703-MR-54
Corradini, 2007, Disease progression and liver cancer in the ferroportin disease, Gut, 56, 1030, 10.1136/gut.2007.122549
Park, 2001, Hepcidin, a urinary antimicrobial peptide synthesized in the liver, J Biol Chem, 276, 7806, 10.1074/jbc.M008922200
Rivera, 2005, Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs, Blood, 106, 2196, 10.1182/blood-2005-04-1766
Nicolas, 2001, Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice, Proc Natl Acad Sci U S A, 98, 8780, 10.1073/pnas.151179498
Roetto, 2003, Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis, Nat Genet, 33, 21, 10.1038/ng1053
Nicolas, 2002, Severe iron deficiency anemia in transgenic mice expressing liver hepcidin, Proc Natl Acad Sci U S A, 99, 4596, 10.1073/pnas.072632499
Weinstein, 2002, Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease, Blood, 100, 3776, 10.1182/blood-2002-04-1260
Nemeth, 2004, Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, Science, 306, 2090, 10.1126/science.1104742
Abboud, 2000, A novel mammalian iron-regulated protein involved in intracellular iron metabolism, J Biol Chem, 275, 19906, 10.1074/jbc.M000713200
Donovan, 2000, Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter, Nature, 403, 776, 10.1038/35001596
McKie, 2000, A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation, Mol Cell, 5, 299, 10.1016/S1097-2765(00)80425-6
Donovan, 2005, The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis, Cell Metab, 1, 191, 10.1016/j.cmet.2005.01.003
Pietrangelo, 2004, The ferroportin disease, Blood Cells Mol Dis, 32, 131, 10.1016/j.bcmd.2003.08.003
Melis, 2008, A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron, Haematologica, 93, 1473, 10.3324/haematol.13342
Rivera, 2005, Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia, Blood, 105, 1797, 10.1182/blood-2004-08-3375
Roy, 2007, Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation, Blood, 109, 4038, 10.1182/blood-2006-10-051755
Elliott, 2009, Hyporesponsiveness to erythropoietin: causes and management, Adv Chronic Kidney Dis, 16, 94, 10.1053/j.ackd.2008.12.004
Sasu B, Hainu M, Boone TC, Bi XJ, Lee KJ, Arvedson T, et al. Hepcidin, hepcidin antagonists and methods of use. Amgen Inc. Patent 12/022,515. 2009. USA. 1-30-2008.
Nicolas, 2002, The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation, J Clin Invest, 110, 1037, 10.1172/JCI0215686
Nemeth, 2003, Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein, Blood, 101, 2461, 10.1182/blood-2002-10-3235
Wrighting, 2006, Interleukin-6 induces hepcidin expression through STAT3, Blood, 108, 3204, 10.1182/blood-2006-06-027631
Pietrangelo, 2007, STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo, Gastroenterology, 132, 294, 10.1053/j.gastro.2006.10.018
Verga Falzacappa, 2007, STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation, Blood, 109, 353, 10.1182/blood-2006-07-033969
Vinzio, 2008, Isolated microcytic anemia disclosing a unicentric Castleman disease: the interleukin-6/hepcidin pathway?, Eur J Intern Med, 19, 367, 10.1016/j.ejim.2007.09.006
Ohsugi, 2007, Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases, Biol Pharmaceut Bull, 30, 2001, 10.1248/bpb.30.2001
Brandt, 1990, Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice, J Clin Invest, 86, 592, 10.1172/JCI114749
Katsume, 2002, Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman's disease like symptoms emerged in IL-6 transgenic mice, Cytokine, 20, 304, 10.1006/cyto.2002.2012
Nishimoto, 2005, Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease, Blood, 106, 2627, 10.1182/blood-2004-12-4602
Kawabata, 2007, Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease, Haematologica, 92, 857, 10.3324/haematol.10794
Sharma, 2008, Involvement of hepcidin in the anemia of multiple myeloma, Clin Cancer Res, 14, 3262, 10.1158/1078-0432.CCR-07-4153
Cazzola, 1996, Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis, Blood, 87, 4824, 10.1182/blood.V87.11.4824.bloodjournal87114824
Huang, 2005, Hemojuvelin acts as a bone morphogenetic protein co-receptor to regulate hepcidin expression [abstract], ASH Annual Meeting Abstracts, 106, 511
Xia, 2008, Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin, Blood, 111, 5195, 10.1182/blood-2007-09-111567
Truksa, 2006, Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6, Proc Natl Acad Sci, 103, 10289, 10.1073/pnas.0603124103
Lin, 2007, Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4, Blood, 110, 2182, 10.1182/blood-2007-04-087593
Babitt, 2007, Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance, J Clin Invest, 117, 1933, 10.1172/JCI31342
Wang, 2005, A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression, Cell Metab, 2, 399, 10.1016/j.cmet.2005.10.010
Andriopoulos, 2009, BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism, Nat Genet, 41, 482, 10.1038/ng.335
Meynard, 2009, Lack of the bone morphogenetic protein BMP6 induces massive iron overload, Nat Genet, 41, 478, 10.1038/ng.320
Papanikolaou, 2004, Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis, Nat Genet, 36, 77, 10.1038/ng1274
Niederkofler, 2005, Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload, J Clin Invest, 115, 2180, 10.1172/JCI25683
Babitt, 2006, Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression, Nat Genet, 38, 531, 10.1038/ng1777
Krijt, 2004, Expression of Rgmc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin, Blood, 104, 4308, 10.1182/blood-2004-06-2422
Constante, 2007, Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor-alpha, Am J Pathol, 170, 497, 10.2353/ajpath.2007.060437
Yang, 2002, Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation, J Biol Chem, 277, 39786, 10.1074/jbc.M201485200
Mueller, 2001, IRP1 activation by extracellular oxidative stress in the perfused rat liver, J Biol Chem, 276, 23192, 10.1074/jbc.M100654200